You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康惠製藥(603139.SH):擬以3264萬元購買山東友幫生化科技51%股權
格隆匯 09-23 16:34

格隆匯 9 月 23日丨康惠製藥(603139.SH)公佈,公司擬以人民幣3264萬元購買來新勝持有的山東友幫生化科技有限公司51%股權。

次交易為陝西康惠製藥股份有限公司根據長期發展戰略需要而作出的決定,目標公司由於政府高鐵項目建設土地重新規劃原因已經於2018起不能正常生產經營,其全資子公司陝西友幫生物醫藥科技有限公司正在建設中,目標公司目前經營業績處於虧損狀態,對公司2020年業績不會產生積極影響,預計對公司的短期業績也不會產生明顯的貢獻。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account